Caring for carers of people with Parkinson's disease

ISRCTN ISRCTN21346995
DOI https://doi.org/10.1186/ISRCTN21346995
Secondary identifying numbers CSA/07/017
Submission date
27/05/2009
Registration date
21/07/2009
Last edited
07/08/2020
Recruitment status
No longer recruiting
Overall study status
Stopped
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Richard Brown
Scientific

King's College London
Institute of Psychiatry
Department of Psychology (PO77)
De Crespigny Park
London
SE5 8AF
United Kingdom

Study information

Study designInterventional multicentre randomised controlled trial (delayed treatment)
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleCaring for carers of people with Parkinson's disease (C4C-PD): a multicentre randomised controlled trial of the development and evaluation of a nurse-led group-based psychological intervention for caregiver stress and distress
Study acronymC4C-PD
Study objectivesIs a psychological group intervention effective in reducing the level of stress and distress experienced by carers of patients with Parkinson's disease?
Ethics approval(s)Joint South London and Maudsley and Institute of Psychiatry NHS Research Ethics Committee, 05/02/2009, ref: 09/H0807/6
Health condition(s) or problem(s) studiedCarer stress; Parkinson's disease
Intervention1. Cognitive behavioural therapy nurse-led group intervention: 6 - 9 carers per group, 8 x 2 hour sessions at weekly intervals over 2 - 3 months. Intervention guided by trial manual and supporting materials.
2. Waiting list group: The waiting list group will be offered treatment after 3 months.
Intervention typeOther
Primary outcome measure28-item General Health Questionnaire (GHQ-28): score at the end of treatment for the immediate treatment group compared to score of the delayed treatment group at the same timepoint. Measured at pre-randomisation and end of treatment (for active arm) or at 3 months (for control arm). All will be assessed again at 3 months post-treatment to assess uncontrolled delayed effects.
Secondary outcome measures1. Zarit Caregiver Burden Interview
2. Caregiver Strain Index
3. Geriatric Depression Scale (GDS-15)

In addition to the analysis at the primary endpoint, (uncontrolled) treatment effects at the end of follow-up relative to baseline and end of treatment will be analysed as a secondary endpoint. All measured at pre-randomisation and end of treatment (for active arm) or at 3 months (for control arm). All will be assessed again at 3 months post-treatment to assess uncontrolled delayed effects.
Overall study start date01/08/2009
Completion date31/12/2010
Reason abandoned (if study stopped)Participant recruitment issue

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants146
Key inclusion criteriaParticipants must:
1. Be the primary caregiver for the person with Parkinson's disease and either live in the same home and/or have at least 12 hours direct care-related contact per week
2. Be able to provide informed consent
3. Be willing and able to attend 8 weekly or fortnightly sessions
4. Score 5 or more ('case' level problems) using binary (0/1) scoring on the 28-item General Health Questionnaire (GHQ-28)
5. Be aged 18 years or older (no upper age limit), males or females
Key exclusion criteriaParticipants will be excluded if they:
1. Lack sufficient spoken language skills and literacy to meaningfully engage with the sessions or complete treatment related activities between sessions
2. Are felt unlikely to comply with the 'rules' that typically apply to participants in group-based interventions (e.g. maintaining confidentiality, allowing others to speak)
3. They have received psychological therapy or a course of counselling in the past year, are currently receiving treatment or counselling, or plan to start in the next year
Date of first enrolment01/08/2009
Date of final enrolment31/12/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

King's College London
London
SE5 8AF
United Kingdom

Sponsor information

King's College London (UK)
University/education

Research Governance/Clinical Trials Facilitator
R&D Office PO05
De Crespigny Park
London
SE5 8AF
England
United Kingdom

Website http://www.kcl.ac.uk/
ROR logo "ROR" https://ror.org/0220mzb33

Funders

Funder type

Charity

Parkinson's Disease Society

No information available

Edmund J Safra Philanthropic Foundation

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

07/08/2020: Study stopped due to poor recruitment.
13/06/2017: Internal review
15/07/2016: No publications found, verifying study status with principal investigator.